Stock JGCHEM J.G. CHEMICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials J.G. Chemicals Limited

Equities

JGCHEM

INE0MB501011

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 12:43:53 05/06/2024 BST 		5-day change 1st Jan Change
206.7 INR +0.05% Intraday chart for J.G. Chemicals Limited -6.49% 0.00%
05-08 J.G. Chemicals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
05-08 J.G. Chemicals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023
Net sales 1 3,994 4,353 6,128 7,846
EBITDA 1 192.5 438.4 561.5 755
EBIT 1 174 415.1 534.8 720.7
Operating Margin 4.36% 9.54% 8.73% 9.19%
Earnings before Tax (EBT) 1 191.1 412 574.5 766.9
Net income 1 129.6 234.4 400 549.4
Net margin 3.24% 5.38% 6.53% 7%
EPS 2 4.080 7.389 12.61 17.32
Free Cash Flow - -229.4 -266.6 8.085
FCF margin - -5.27% -4.35% 0.1%
FCF Conversion (EBITDA) - - - 1.07%
FCF Conversion (Net income) - - - 1.47%
Dividend per Share - - - -
Announcement Date 06/01/23 06/01/23 06/01/23 19/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023
Net Debt 1 517 693 881 665
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) 2.686 x 1.581 x 1.569 x 0.8811 x
Free Cash Flow - -229 -267 8.09
ROE (net income / shareholders' equity) - 27.5% 31.3% 30.7%
ROA (Net income/ Total Assets) - 14.4% 14.1% 16%
Assets 1 - 1,623 2,837 3,427
Book Value Per Share 2 26.80 34.20 48.10 65.50
Cash Flow per Share 2 0.2200 1.480 1.850 1.120
Capex 1 54.1 53.8 89.7 98.9
Capex / Sales 1.35% 1.24% 1.46% 1.26%
Announcement Date 06/01/23 06/01/23 06/01/23 19/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
J.G. CHEMICALS LIMITED Stock J.G. Chemicals Limited
0.00% 96.91M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+41.20% 750B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.11% 606B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 356B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.78% 326B
ABBVIE INC. Stock AbbVie Inc.
+5.57% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.70% 246B
ROCHE HOLDING AG Stock Roche Holding AG
-3.44% 213B
NOVARTIS AG Stock Novartis AG
+10.79% 213B
PFIZER, INC. Stock Pfizer, Inc.
+1.64% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. JGCHEM Stock
  4. Financials J.G. Chemicals Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW